J&J Imbruvica gains EU approval for untreated Mantle Cell Lymphoma in transplant eligible patients Ruchika Sharma25 July 2025 12:40 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the European Commission (EC) has approved an...
JnJ Darzalex gets European Commission nod for high-risk smouldering multiple myeloma Ruchika Sharma24 July 2025 12:15 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has received approval from the European Commission (EC) for a new...
JnJ seeks USFDA approval for Icotrokinra to treat plaque psoriasis in adults, adolescents Ruchika Sharma22 July 2025 11:30 AM ISTIcotrokinra was jointly discovered and is being developed pursuant to the license and collaboration agreement between Protagonist and Johnson &...
JnJ gets USFDA priority review for TAR 200 NDA in high-risk non-muscle invasive bladder cancer Ruchika Sharma19 July 2025 10:30 AM ISTRaritan: Johnson & Johnson has received priority review from the U.S. Food and Drug Administration (FDA) for the New Drug Application...
JnJ eyes expanded USFDA approval for Caplyta for prevention of relapse in schizophrenia Ruchika Sharma9 July 2025 12:30 PM ISTTitusville: Johnson & Johnson has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) based...
JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterations Ruchika Sharma6 July 2025 12:30 PM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced the submission of an extension of indication application...
Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag International Ruchika Sharma22 Jun 2025 5:30 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
JnJ seeks USFDA nod of Stelara for pediatric Crohn's disease Ruchika Sharma18 Jun 2025 11:58 AM ISTHorsham: Johnson & Johnson is seeking the U.S. Food and Drug Administration (FDA) approval for the expansion of STELARA (ustekinumab) for the...
JnJ elects JPMorganChase President Daniel Pinto to its Board of Directors Ruchika Sharma11 Jun 2025 4:07 PM ISTNew Brunswick: Johnson & Johnson has elected JPMorganChase's President Daniel Pinto to its Board of Directors.Pinto is a prominent business...
Icotrokinra results show significant skin clearance in patients with difficult to treat scalp, genital psoriasis: JnJ Ruchika Sharma12 May 2025 10:30 AM ISTSpring House: Johnson & Johnson has announced new data from the Phase 3 ICONIC-TOTAL study investigating icotrokinra (JNJ-2113), the...
Johnson & Johnson Medtech, Qure.ai partner to enhance early detection of lung cancer in India Ruchika Sharma11 May 2025 11:00 AM ISTMumbai: Johnson & Johnson MedTech has onboarded Qure.ai as a strategic partner with Johnson & Johnson Private Limited, a Johnson &...
JnJ backed HistoSonics explores sale at USD 2.5 billion valuation: Report Ruchika Sharma2 May 2025 10:30 AM ISTJohnson & Johnson backed HistoSonics is exploring a potential sale at a valuation of over USD 2.5 billion, following a wave of...
